Take the Next Step

Enter your email address to stay informed with the latest information about portfolio monitoring

Magnifying Glass

Check for Losses!

Kaplan Fox has the experience, skills, and resources to aggressively pursue our clients' rights on issues of securities fraud.

Contact Us to Start

Current Case Investigations

Synergy Pharmaceuticals Inc.

February 23, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Synergy Pharmaceuticals Inc. (“Synergy” or the “Company”) (NASDAQ: SGYP).  Investors who purchased Synergy securities between September 5, 2017 and November 14, 2017, inclusive (the “Class Period”), may be affected.

Super Micro Computer, Inc.

February 23, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI).  Investors who purchased Super Micro securities between August 5, 2016 and January 30, 2018, inclusive (the “Class Period”), may be affected.

MiMedx Group, Inc.

February 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG), a developer and marketer of regenerative and therapeutic biologics, concerning potential securities law violations.  Investors who purchased MiMedx shares may be affected.

Quantum Corporation

February 12, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Quantum Corporation (“Quantum” or the “Company”) (NYSE: QTM).  Investors who purchased shares of Quantum common stock may be affected.

TrueCar, Inc.

February 7, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of TrueCar, Inc. (“TrueCar” or the “Company”) (NASDAQ:  TRUE).  Investors who purchased TrueCar common stock may be affected.

Load More

Settlement Filing Deadlines

Company Ticker Class Period Deadline Administrator
Xencor, Inc. XNCR On behalf of all former holders of Xencor, Inc.'s (the "Company") Series A-E preferred stock whose shares were converted to A-1 stock in the Recapitalization. 5/13/17 Strategic Claims Services  
Molycorp, Inc. MCP 2/21/2012 - 10/15/2013 5/18/17 Angeion Group  
Health Enhancement Products, Inc. (N/K/A Zivo Bioscience, Inc.) HEPI 10/31/2003 - 5/31/2004 5/18/17 Rust Consulting, Inc.  
Barclays Bank PLC (Electronic Foreign Exchange Trading - BARX) n/a 6/1/2008 - 4/21/2016 5/19/17 Garden City Group  
EZCORP, Inc. EZPW 4/19/2012 - 10/6/2014 5/19/17 Garden City Group  
King Digital Entertainment plc KING 3/26/2014 - 9/22/2014 5/23/17 Gilardi & Co.  
Load More